Malignant neoplasm of breast of unspecified site, female
ICD-10 C50.91 is a billable code used to indicate a diagnosis of malignant neoplasm of breast of unspecified site, female.
C50.91 refers to a malignant neoplasm of the breast in females where the specific site of the tumor is not specified. Breast cancer is a heterogeneous disease characterized by uncontrolled cell growth in breast tissue. It can arise from various locations within the breast, including the ducts (ductal carcinoma) or lobules (lobular carcinoma). Hormone receptor status, including estrogen receptor (ER) and progesterone receptor (PR) positivity, plays a crucial role in determining treatment options and prognosis. Additionally, the human epidermal growth factor receptor 2 (HER2) status is vital for targeted therapies. Staging of breast cancer is typically done using the AJCC (American Joint Committee on Cancer) system, which considers tumor size, lymph node involvement, and metastasis. Treatment protocols may include surgery, radiation therapy, chemotherapy, hormone therapy, and targeted therapy, depending on the cancer's characteristics and stage. Accurate coding is essential for appropriate treatment planning and reimbursement.
Detailed pathology reports, imaging studies, and treatment plans must be documented.
Initial diagnosis of breast cancer, treatment planning, and follow-up care.
Ensure accurate recording of hormone receptor and HER2 status for treatment decisions.
Imaging reports must clearly indicate findings related to breast masses.
Mammography findings suggestive of malignancy, ultrasound-guided biopsies.
Radiologists should provide detailed descriptions of imaging findings to support coding.
Used when a patient undergoes a lumpectomy for breast cancer treatment.
Operative report detailing the procedure and findings.
Oncologists must ensure that the diagnosis aligns with the surgical procedure performed.
C50.91 indicates a malignant neoplasm of the breast in females where the specific site of the tumor is not specified. It is important for coders to ensure that all relevant clinical information is documented to support this diagnosis.
